Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Gomez-Almaguer, MD
Hospital Universitario "Dr. José Eleuterio González"
Principal Investigator - Héctor R Martínez-Rodríguez, MD PhD
Hospital Universitario "Dr. José Eleuterio González"
Study Chair - Jose C Jaime-Pérez, MD PhD
Hospital Universitario "Dr. José Eleuterio González"
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Servicio Hematología Hospital Universitario
Monterrey, Nuevo León, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 31 Jan 2014
- Completion
- 30 Jun 2014
- Last update posted
- 3 Apr 2015
- Registered enrollment
- 14
- Registry id
- NCT01933321
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.